This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.
CLSI M33-A
$136.00
Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE
Category: CLSI
Related products
$90.00
$103.00
$97.00
$100.00
$114.00